
Legumes · Legume
Edamame (Green Soybeans)
Glycine max · also called Green soybeans, immature soybeans, mukimame (shelled edamame), soja verde (Spanish)
Edamame are soybeans picked while still young and green, eaten steamed or boiled from the pod. They give plant protein, fibre and folate. Trials of soy protein in place of other protein found a small fall in LDL cholesterol, but edamame themselves have not been tested. The main cautions are soy allergy (a major food allergen, sometimes severe), possible effects on thyroid tablets, and gas in sensitive people.
General information, not medical advice. Last substantive update · Not medically reviewed. A named clinician has not signed off on this page. How this page is made
About Edamame (Green Soybeans)
Edamame are soybeans picked while still young and green, eaten steamed or boiled. They are rich in plant protein, fibre and folate. They are a nutritious food, not a proven remedy: the cholesterol findings come from trials of soy protein in place of other protein, and the heart and cancer findings come from observational studies of soy or legumes in general.
What it is
Edamame are the green, immature seeds of the soybean plant (Glycine max), a member of the legume family. They are eaten from the pod, steamed or boiled, or shelled. Mature soybeans, harvested later, are the beans used for tofu.
USDA data for boiled, shelled green soybeans without salt: 141 kcal per 100 g. One cup (180 g) has about 254 kcal, 22 g protein, 7.6 g fibre, 200 micrograms folate (DFE), 4.5 mg iron, 970 mg potassium and 108 mg magnesium. Frozen, unprepared edamame is a different USDA item: 109 kcal, 11.2 g protein and 4.8 g fibre per 100 g, with 31.4 micrograms of vitamin K. Pods are not eaten, so package weights that include pods overstate the beans.
What the research shows
Pooled trials of soy protein in place of other protein found LDL cholesterol about 4.8 mg/dL lower (roughly 3 to 4%) over a median 6 weeks. That is a small change, and the trials used soy protein in many forms, not edamame. In postmenopausal women, soy protein supplements of 25 g a day or more lowered systolic blood pressure by about 3 mmHg.
Follow-up studies link more legumes to slightly less heart disease (RR 0.94 for cardiovascular disease, 0.90 for coronary heart disease, no link with stroke), and higher soy intake to fewer deaths from cancer and cardiovascular disease. These cannot show cause.
Isoflavones are estrogen-like plant compounds; one laboratory study found them at lower levels in edamame varieties than in tofu varieties. Isoflavone supplements gave a small overall menopause benefit but no significant effect on hot flushes. A 2021 analysis of 41 clinical studies found no change in male hormone levels. For breast cancer, observational studies are mixed and limited, and NCCIH says soy supplements have not been shown to lower risk.
We read no trial of edamame itself.
Food versus supplements and soy products
Most trials of soy and health used soy protein powders, isolates or isoflavone supplements, and NCCIH says effects may differ by product. Soy protein trials compared soy with other protein, so they describe a swap, not an add-on. Tofu, soy milk, soy sauce and supplements are different products; we make no claim about them here.
Portions
The NHS counts 80 g of pulses and beans, including soy beans, as one portion of 5 A DAY, and pulses count only once a day however much you eat. This page gives no amounts to eat. Ask a doctor, pharmacist or dietitian what is right for you, especially if you have a food allergy, kidney disease, take thyroid medicine, warfarin or an MAOI.
At a glance
Traditional uses history, not proof
- Eaten steamed or boiled as a snack, side dish or in salads, in the pod or shelled
- Long use as food is not proof that it treats any condition
Studied for research
- Plant protein, fibre and folate, high certainty for the nutrient content
- Cholesterol, moderate certainty for soy protein in place of other protein, not tested with edamame
- Heart disease, low certainty (observational, legumes as a group)
- Blood pressure, low certainty (soy protein supplements in postmenopausal women)
- Menopause symptoms, mixed (isoflavone supplements, no significant effect on hot flushes)
- Breast cancer risk and survival, low certainty (observational, soy in general)
- Male hormones, moderate certainty of no change (soy protein and isoflavones)
- Bone density and type 2 diabetes, low or insufficient (agency summary only)
Main compounds
- Plant protein
- Dietary fibre
- Folate
- Isoflavones
- Potassium
- Vitamin K (frozen edamame)
Common forms
- Steamed or boiled edamame in the pod
- Shelled edamame (mukimame); the USDA values read are for shelled beans
- Frozen edamame (USDA lists it separately)
- Lightly salted or seasoned edamame (check the label)
- Soy protein powders, isoflavone supplements, tofu, soy milk and soy sauce are different products and are not covered
Research links: 2019 analysis: soy protein and LDL cholesterol · 2023 review: soy and thyroid tablets · NCCIH: soy usefulness and safety · Research Library · Genes & Biomarkers Library
What it is and its history
- Accepted scientific name
- Glycine max
- Naming authority
- (L.) Merr. (GBIF accepted)
- Common names
- Edamame (English); Green soybeans (English); Immature soybeans (English); Mukimame (shelled edamame) (English); Soja verde, edamame (Spanish)
- Family or group
- Fabaceae (the legume or pea family), as given by GBIF.
- Classification
- Plantae > Tracheophyta > Magnoliopsida > Fabales > Fabaceae > Glycine > Glycine max
- Native range
- Not verified from a source read. NCCIH says soybeans have long been cultivated in Asia and are now also produced in other parts of the world, including the United States.
- Habitat
- Not verified from a source read.
- What it looks like
- Roots: Not verified.; Stems: Not verified.; Leaves: Not verified.; Flowers: Not verified.; Fruit: Edamame are the soybean seeds picked while still immature and green, eaten from the pod (existing nutrient summary). USDA gives a household portion of 1 cup of shelled cooked beans = 180 g and 1 cup of frozen, unprepared edamame = 118 g.
- Cultivation
- Not verified from a source read.
- Harvest and processing
- Sold in the pod or shelled (mukimame), fresh or frozen, plain or lightly salted or seasoned (existing nutrient summary). A laboratory study describes edamame varieties as harvested while the seeds are still immature and tofu varieties as harvested when the seeds are mature.
- Look-alikes and adulterants
- Name: Mature soybeans, tofu, soy milk and soy sauce; Note: Made from mature soybeans; nutrient values and effects differ. Mature raw soybeans have 446 kcal and 36.5 g protein per 100 g by USDA because they hold little water.; Name: Soy protein and isoflavone supplements; Note: Concentrated products; most trials of soy and health used these, not edamame.
- Sustainability and conservation
- Not assessed.
Photographs

What is inside, and how it may work
What it contains and how those compounds act in cells and animals. Laboratory and animal mechanisms are not proven effects in people.
Main compounds
| Compound | Family | Where it is concentrated | Activity studied | Level of evidence |
|---|---|---|---|---|
| Plant protein | protein | Seed USDA: 12.4 g per 100 g boiled shelled beans; 11.2 g per 100 g frozen, unprepared | Soy is a protein-rich legume; NCCIH says soy protein in place of other proteins may lower cholesterol to a small extent. 22 21 18 1 | Human data |
| Dietary fibre | carbohydrate | Seed USDA: 4.2 g per 100 g boiled shelled; 4.8 g per 100 g frozen, unprepared | A fibre food; the soluble and insoluble split was not read. 22 21 | Composition |
| Folate | B vitamin | Seed USDA: 111 micrograms DFE per 100 g boiled shelled; 303 micrograms DFE per 100 g frozen, unprepared | A B vitamin; content only, no trial of edamame read. 22 21 | Composition |
| Isoflavones (daidzein, genistein, glycitein) | isoflavone (phytoestrogen) | Seed Laboratory study of 30 varieties: total isoflavones 0.02 to 0.12% in edamame varieties and 0.16 to 0.25% in tofu varieties | NCCIH describes isoflavones as compounds similar in structure to the hormone estrogen. Laboratory chemistry does not show what edamame do in the body. 12 18 | Laboratory research |
| Potassium | mineral | Seed USDA: 539 mg per 100 g boiled shelled; 482 mg per 100 g frozen, unprepared | Relevant to people on a potassium limit. 22 21 16 | Composition |
| Vitamin K (phylloquinone) | vitamin | Seed USDA: 31.4 micrograms per 100 g frozen, unprepared edamame; no value listed for the boiled item | Relevant to people on warfarin. 21 17 | Composition |
Mechanisms, receptors and pathways
| Target or pathway | Gene or receptor | What was found | Level |
|---|---|---|---|
| Soy protein and blood cholesterol | Not specified in the sources read | NCCIH says consuming soy protein in place of other proteins may lower cholesterol to a small extent, and that isoflavones may not have the same effect. Mechanism not established in the abstract read. 18 1 | Human data |
| Isoflavones and estrogen-like activity | Estrogen receptors are not named in the sources read | NCCIH describes isoflavones as similar in structure to estrogen. A 2021 pooled analysis found no change in male reproductive hormone levels with soy protein or isoflavones, and a 2025 analysis found a small overall benefit for menopausal symptoms but none for hot flushes. 18 8 4 | Human data |
Absorption, metabolism and elimination
- Absorption
- Not found for edamame. A 2023 review discusses whether soy products change levothyroxine absorption.
- Distribution
- Not found.
- Metabolism
- Not found.
- Elimination
- Not found.
- Bioavailability
- Not established for edamame isoflavones or nutrients in the sources read.
Isolated compounds versus whole extracts
The cholesterol and blood pressure trials used soy protein (powders, isolates and soy foods) in place of other protein, or isoflavone supplements. That describes a swap or a supplement, not edamame on top of a usual diet. NCCIH separates soy foods from soy protein and isoflavone supplements and says effects may differ by product. The follow-up studies are about soy foods or legumes in general. We read no trial that fed people edamame and measured cholesterol, heart attacks or cancer.
Nutritional composition
Nutrition from USDA FoodData Central (SR Legacy, April 2018 release; values read 2026-10-26 from a saved copy of the data feed). Boiled, drained green soybeans without salt, shelled (FDC 169283), per 100 g: 141 kcal, 12.4 g protein, 6.4 g fat (0.74 g saturated), 11.0 g carbohydrate, 4.2 g fibre, about 69 g water, 145 mg calcium, 2.5 mg iron, 60 mg magnesium, 158 mg phosphorus, 539 mg potassium, 14 mg sodium, 17 mg vitamin C, 111 micrograms folate (DFE), 0.26 mg thiamin and 0.502 mg manganese. One cup of shelled beans (180 g) is about 254 kcal, 22 g protein, 11.5 g fat, 7.6 g fibre, 200 micrograms folate, 4.5 mg iron, 970 mg potassium and 108 mg magnesium (the per-100 g values multiplied by 1.8). USDA lists no vitamin K value for this item. Frozen, unprepared edamame (FDC 168410), per 100 g: 109 kcal, 11.2 g protein, 4.73 g fat, 7.61 g carbohydrate, 4.8 g fibre, 60 mg calcium, 2.11 mg iron, 482 mg potassium, 6 mg sodium, 303 micrograms folate (DFE) and 31.4 micrograms vitamin K; its cup portion is 118 g. Raw mature soybeans (FDC 174270), per 100 g: 446 kcal and 36.5 g protein, because they hold only about 8.5 g of water. Compare cooked with cooked. The pods are not eaten, so weights that include pods overstate the beans. Values vary with variety, growing place, freezing and cooking.
1 high certainty2 moderate certainty1 mixed findings5 low certainty1 very low certainty1 not enough evidence
What was looked at
The 11 benefits and uses checked for Edamame (Green Soybeans), each with how strong the evidence is. Tap one to open it.
- Plant protein, fibre and folate (nutrient content)High certainty
- Cholesterol (soy protein in place of other protein)Moderate certainty
- Heart disease (legumes, observational)Low certainty
- Blood pressureLow certainty
- Menopause symptoms (isoflavones)Mixed findings
- Breast cancer risk and survival (soy, observational)Low certainty
- Living longer (soy, observational)Low certainty
- Male hormones (a concern, no effect found)Moderate certainty
- Bone density after menopause (agency summary)Low certainty
- Type 2 diabetes risk and blood sugar (agency summary)Not enough evidence
- Obesity (pulses, observational)Very low certainty
Lab markers tracked in the studies
LDL cholesterolTotal cholesterolSystolic blood pressureDiastolic blood pressureTotal testosterone (men)Estradiol (men)Menopausal symptom score
What is Edamame (Green Soybeans) good for?
The main studied uses and how strong the human evidence is for each. Most results are for soy protein, isoflavone supplements or soy and legumes in general. We read no trial of edamame itself.
Benefits, one by one
Each card is a research question, not a promise. Tap a goal to filter. Open a card to see the studies, doses and limits.
Plant protein, fibre and folate (nutrient content)
High certaintyCooked, shelled edamame have 12.4 g of protein, 4.2 g of fibre and 111 micrograms of folate per 100 g, by USDA data. One cup (180 g) has about 22 g of protein, 7.6 g of fibre and 200 micrograms of folate.
2 studiesSteamed or boiled shelled edamame as food.
Studies, doses and limits
What the trials found
USDA FoodData Central lists boiled green soybeans (shelled, no salt) at 141 kcal, 12.4 g protein, 4.2 g fibre and 111 micrograms folate (DFE) per 100 g. Frozen, unprepared edamame (a different USDA item) has 109 kcal, 11.2 g protein, 4.8 g fibre and 303 micrograms folate (DFE) per 100 g.
Results
This is a plain nutrient fact, not a trial. It does not show that eating edamame treats any condition. Frozen and cooked values differ, so compare like with like.
Effect sizes as reported
Cooked shelled: 141 kcal, 12.4 g protein, 4.2 g fibre, 111 micrograms folate (DFE) per 100 g; per 1 cup (180 g): about 254 kcal, 22 g protein, 7.6 g fibre, 200 micrograms folate.
Why this rating
High for the nutrient content (a reference database), not for any health effect.
Form and dose studied
Steamed or boiled shelled edamame as food.
Who was studied
General diet.
Limits
Values change with variety, growing place, freezing and cooking. USDA SR Legacy data are from 2018. Values here are for the beans, not the pods.
Why researchers looked
Edamame are young soybeans, so people ask what the food gives in protein, fibre and vitamins.
Traditional use
Edamame are eaten steamed or boiled, in the pod or shelled, as a snack, side dish or in salads. Long use as food is not proof that it treats any condition.
Proposed mechanism Composition
Not applicable: this is nutrient content.
A proposed mechanism does not show that the effect happens in people.
Soy is a major food allergen; see the Safety tab.
Cholesterol (soy protein in place of other protein)
Moderate certaintyIn pooled trials, soy protein in place of other protein lowered LDL ("bad") cholesterol by about 4.8 mg/dL (roughly 3 to 4%). The trials used soy protein in many forms, not edamame in particular.
2 studiesSoy protein (many forms) in place of other protein; edamame were not …
Studies, doses and limits
What the trials found
A pooled analysis of 46 trials the US FDA was reviewing (43 gave usable data) found soy protein, at a median 25 g a day for a median 6 weeks, lowered LDL by 4.76 mg/dL and total cholesterol by 6.41 mg/dL compared with non-soy protein. About three quarters of the individual trials showed an LDL fall, though only a minority were significant on their own. NCCIH (2025 page) agrees the effect is small.
Results
A small average fall for soy protein in place of other protein. It is a swap, not an add-on, and not a treatment for high cholesterol. We did not read a trial that fed people edamame and measured cholesterol.
Effect sizes as reported
LDL -4.76 mg/dL (95% CI -6.71 to -2.80); total cholesterol -6.41 mg/dL (-9.30 to -3.52).
Why this rating
Moderate for soy protein: pooled randomised trials with a consistent direction but small size, moderate to high spread between trials (I2 55% to 74%) and an industry-linked author. Low for edamame itself, which was not tested.
Form and dose studied
Soy protein (many forms) in place of other protein; edamame were not the tested food.
Who was studied
Adults with LDL 110 to 201 mg/dL.
Limits
Short trials (median 6 weeks). Soy protein is not edamame. One author is at the Soy Nutrition Institute.
Why researchers looked
Soy protein was long allowed on US labels for heart health, and the US FDA was reconsidering that claim, so researchers pooled the trials it was looking at.
Traditional use
Edamame are eaten steamed or boiled, in the pod or shelled, as a snack, side dish or in salads. Long use as food is not proof that it treats any condition.
Proposed mechanism Not established
Not established in the abstract. NCCIH says soy protein in place of other protein may lower cholesterol to a small extent and that isoflavones may not have the same effect.
A proposed mechanism does not show that the effect happens in people.
None specific beyond allergy and digestion (see the Safety tab).
Heart disease (legumes, observational)
Low certaintyPeople who ate the most legumes had slightly less heart disease in follow-up studies (about 6% less cardiovascular disease and 10% less coronary heart disease), but no difference in stroke. Soybeans were not separated out.
2 studiesLegumes as eaten in the diet (soybeans not analysed separately in the…
Studies, doses and limits
What the trials found
A 2023 review of 26 observational studies found the highest legume intake linked to cardiovascular disease RR 0.94 (95% CI 0.89 to 0.99), coronary heart disease RR 0.90 (0.85 to 0.96) and stroke RR 1.00 (0.93 to 1.08). A 2019 umbrella review of cohort studies of pulses with or without other legumes found cardiovascular disease RR 0.92 and coronary heart disease RR 0.90 and graded the certainty low for cardiovascular disease and very low for coronary heart disease.
Results
A small link in observational studies. They cannot show that legumes caused the difference, and they cover legumes in general, not edamame or soy.
Effect sizes as reported
Cardiovascular disease RR 0.94 and 0.92; coronary heart disease RR 0.90; stroke RR 1.00 (no link).
Why this rating
Low or very low: observational cohorts (GRADE low for cardiovascular disease and very low for coronary heart disease in the 2019 review), legumes as a group.
Form and dose studied
Legumes as eaten in the diet (soybeans not analysed separately in the abstracts read).
Who was studied
Adults in cohort studies.
Limits
Observational, so no proof of cause. Healthier people may eat more legumes. Not about edamame.
Why researchers looked
Beans and other legumes are plant protein and fibre foods, so researchers ask whether eating them goes with fewer heart problems.
Traditional use
Edamame are eaten steamed or boiled, in the pod or shelled, as a snack, side dish or in salads. Long use as food is not proof that it treats any condition.
Proposed mechanism Not established
Not established.
A proposed mechanism does not show that the effect happens in people.
None specific.
Blood pressure
Low certaintyPooled trials of soy protein supplements in postmenopausal women found a small fall in blood pressure (about 3 mmHg systolic), seen at 25 g a day of soy protein or more. Follow-up studies of pulses link higher intake to less high blood pressure (RR 0.91, very low certainty).
3 studiesSoy protein supplements in the trials; pulses as food in the cohorts.
Studies, doses and limits
What the trials found
A 2017 pooled analysis of 12 trials in 1,551 postmenopausal women found soy protein lowered systolic pressure by 3.03 mmHg and diastolic by 0.71 mmHg. Only 25 g a day or more of soy protein (or 100 mg a day or more of isoflavones) showed an effect; smaller amounts showed none. A 2019 umbrella review of cohort studies found hypertension RR 0.91 (0.86 to 0.97), graded very low certainty. NCCIH says soy isoflavones may modestly lower blood pressure.
Results
A small effect for supplement-sized amounts of soy protein in one group (postmenopausal women). It is not a blood pressure treatment, and it was not tested with edamame.
Effect sizes as reported
Systolic -3.03 mmHg (95% CI -5.03 to -1.02); diastolic -0.71 mmHg (-1.26 to -0.16); pulses and hypertension RR 0.91.
Why this rating
Low: randomised trials but one group, supplements not food, and spread between trials; the cohort result is graded very low.
Form and dose studied
Soy protein supplements in the trials; pulses as food in the cohorts.
Who was studied
Postmenopausal women (trials); adults in cohorts.
Limits
Postmenopausal women only. The effective amount in the trials was supplement-sized. Not edamame.
Why researchers looked
Soy protein and isoflavones have been studied for blood pressure, and NCCIH says isoflavones may lead to a modest fall.
Traditional use
Edamame are eaten steamed or boiled, in the pod or shelled, as a snack, side dish or in salads. Long use as food is not proof that it treats any condition.
Proposed mechanism Not established
Not established; the trial authors suggest the isoflavones may play a part.
A proposed mechanism does not show that the effect happens in people.
People taking blood pressure medicine should ask their clinician before big diet changes.
Menopause symptoms (isoflavones)
Mixed findingsA 2025 pooled analysis of isoflavone studies in perimenopausal women found a small overall symptom benefit, but no significant effect on hot flushes or sweating. NCCIH calls the effect on hot flashes small and not completely consistent.
3 studiesIsoflavone supplements in the studies, not edamame.
Studies, doses and limits
What the trials found
The 2025 analysis (12 studies; 7 studies with 533 women for the overall score) found overall symptoms improved (Hedges g -0.25, 95% CI -0.42 to -0.08). Headache, psychosocial symptoms, palpitation and depression scores also improved, but hot flushes, sweating, insomnia and vasomotor symptoms did not change significantly. The authors say the studies were small. NCCIH (2025 page) says soy isoflavone supplements or soy protein may reduce hot flash frequency and severity, but the effect may be small and results have been inconsistent.
Results
A small, mixed result from supplements. It does not show that eating edamame eases menopause symptoms.
Effect sizes as reported
Overall symptoms g -0.25 (95% CI -0.42 to -0.08); depression g -0.72; hot flushes: no significant effect.
Why this rating
Mixed: small studies, an overall benefit but no significant effect on hot flushes, the symptom most people ask about.
Form and dose studied
Isoflavone supplements in the studies, not edamame.
Who was studied
Perimenopausal women.
Limits
Small studies. Isoflavone preparations, not food. Edamame have less isoflavone than mature soybeans in a laboratory analysis of 30 varieties.
Why researchers looked
Soy isoflavones are plant compounds similar in structure to the hormone estrogen, so they have been tested for menopause symptoms.
Traditional use
Edamame are eaten steamed or boiled, in the pod or shelled, as a snack, side dish or in salads. Long use as food is not proof that it treats any condition.
Proposed mechanism Not established
Isoflavones are described by NCCIH as similar in structure to estrogen; how they act in the body was not established in the sources read.
A proposed mechanism does not show that the effect happens in people.
Isoflavone supplements are concentrated; ask a clinician, especially if you have had a hormone-linked cancer.
Breast cancer risk and survival (soy, observational)
Low certaintyIn follow-up studies, higher soy intake before a breast cancer diagnosis went with slightly better overall survival; intake after diagnosis was not significantly linked. A large Chinese cohort found no link between moderate soy intake and getting breast cancer.
3 studiesSoy foods and isoflavones as usually eaten, not edamame specifically.
Studies, doses and limits
What the trials found
A 2019 analysis of 12 articles (37,275 women with breast cancer) found pre-diagnosis soy and isoflavone intake linked to overall survival HR 0.84 (95% CI 0.71 to 0.98) but not clearly to breast cancer-specific survival (HR 0.89, 0.74 to 1.07); post-diagnosis links with survival were not significant. Both were linked to less recurrence. The authors call this limited evidence. In the China Kadoorie Biobank (over 300,000 women, 2,289 breast cancers), the top versus bottom quarter of isoflavone intake gave RR 1.00 (0.81 to 1.22), while a meta-analysis found each 10 mg a day linked to 3% lower risk. NCCIH says observational studies link higher soy intake with lower breast cancer risk in Asian and Asian-American women, and that soy supplements have not been shown to reduce risk.
Results
Mixed and observational. It does not show that eating soy prevents or treats breast cancer, and no abstract read links soy food to higher risk.
Effect sizes as reported
Pre-diagnosis overall survival HR 0.84; cohort RR 1.00 for moderate intake; meta-analysis 3% lower risk per 10 mg a day of isoflavones.
Why this rating
Low: observational studies with mixed results, soy in general rather than edamame, and an agency note that supplements have not been shown to help.
Form and dose studied
Soy foods and isoflavones as usually eaten, not edamame specifically.
Who was studied
Women, mostly in Asian and Asian-American populations; women with breast cancer for the survival results.
Limits
Observational. Soy intake in many cohorts is low. People with breast cancer should ask their oncology team about soy supplements.
Why researchers looked
Isoflavones resemble estrogen, so people ask whether soy foods raise or lower the risk of breast cancer.
Traditional use
Edamame are eaten steamed or boiled, in the pod or shelled, as a snack, side dish or in salads. Long use as food is not proof that it treats any condition.
Proposed mechanism Not established
Not established.
A proposed mechanism does not show that the effect happens in people.
See the Safety tab for soy supplements and hormone-linked cancers.
Living longer (soy, observational)
Low certaintyIn follow-up studies, higher soy intake was linked to fewer deaths from cancer (RR 0.88) and from cardiovascular disease (RR 0.85). Soy protein alone was not significantly linked to all-cause or cardiovascular deaths.
1 studiesSoy foods and nutrients as eaten.
Studies, doses and limits
What the trials found
A 2019 analysis of 23 prospective studies (330,826 people) found soy and soy products linked to cancer deaths RR 0.88 (95% CI 0.79 to 0.99) and cardiovascular deaths RR 0.85 (0.72 to 0.99). The highest isoflavone intake group had a 10% lower risk of dying from any cause. Soy protein was not significantly linked to all-cause or cardiovascular deaths.
Results
A modest link in observational studies of soy in general. It cannot show cause, and edamame were not analysed on their own.
Effect sizes as reported
Cancer deaths RR 0.88; cardiovascular deaths RR 0.85; all-cause deaths 10% lower in the top isoflavone group.
Why this rating
Low: observational, with differences between groups of people who eat more or less soy.
Form and dose studied
Soy foods and nutrients as eaten.
Who was studied
Adults in cohort studies.
Limits
Observational. Not edamame specifically.
Why researchers looked
Soy foods are a large part of some diets, so researchers compare how long people with high and low soy intake live.
Traditional use
Edamame are eaten steamed or boiled, in the pod or shelled, as a snack, side dish or in salads. Long use as food is not proof that it treats any condition.
Proposed mechanism Not established
Not established.
A proposed mechanism does not show that the effect happens in people.
None specific.
Male hormones (a concern, no effect found)
Moderate certaintyA 2021 pooled analysis of 41 clinical studies found that soy protein or isoflavone intake did not change testosterone, estradiol or estrone in men, whatever the dose or study length.
1 studiesSoy foods, soy protein and isoflavone extracts.
Studies, doses and limits
What the trials found
The 2021 analysis of 41 studies (total testosterone measured in 1,753 men, free testosterone in 752, estradiol in 1,000, estrone in 239) found no significant effect of soy protein or isoflavones on total or free testosterone, estradiol, estrone or sex hormone binding globulin. Subgroups by isoflavone dose and by study length also showed no effect.
Results
Reassuring for hormone levels, but it measured blood hormones, not fertility or breast tissue, and it used soy protein, foods and extracts, not edamame.
Effect sizes as reported
No significant change in total testosterone, free testosterone, estradiol or estrone.
Why this rating
Moderate that hormone levels do not change: pooled clinical studies with a consistent finding, but not edamame and an author linked to a soy-related company.
Form and dose studied
Soy foods, soy protein and isoflavone extracts.
Who was studied
Adult men.
Limits
Hormone levels only. One author is affiliated with Nutrition Matters, Inc. Funding is not stated in the abstract.
Why researchers looked
Because isoflavones resemble estrogen, people worry that soy could feminize men, so researchers measured hormone levels.
Traditional use
Edamame are eaten steamed or boiled, in the pod or shelled, as a snack, side dish or in salads. Long use as food is not proof that it treats any condition.
Proposed mechanism Not established
Not established; the analysis found no hormone change.
A proposed mechanism does not show that the effect happens in people.
None specific.
Bone density after menopause (agency summary)
Low certaintyNCCIH says soy isoflavones probably have a beneficial effect on bone density in postmenopausal women.
1 studiesIsoflavones (studies were of isoflavone preparations; edamame were no…
Studies, doses and limits
What the trials found
We read only the NCCIH summary statement. The reviews it cites were not opened, and no figures were read.
Results
A short agency statement about isoflavones, not edamame.
Effect sizes as reported
No figures read.
Why this rating
Low: an agency summary statement only; the underlying studies were not re-read.
Form and dose studied
Isoflavones (studies were of isoflavone preparations; edamame were not the tested food).
Who was studied
Postmenopausal women.
Limits
No data were read for this entry.
Why researchers looked
Isoflavones resemble estrogen, which affects bone, so they have been tested for bone loss after menopause.
Traditional use
Edamame are eaten steamed or boiled, in the pod or shelled, as a snack, side dish or in salads. Long use as food is not proof that it treats any condition.
Proposed mechanism Not established
Not established in the source read.
A proposed mechanism does not show that the effect happens in people.
None specific.
Type 2 diabetes risk and blood sugar (agency summary)
Not enough evidenceNCCIH says people who eat diets high in soy may have a lower risk of type 2 diabetes, and that it is uncertain whether soy products improve blood sugar control in people who already have it. A pulse analysis of cohort studies found no link between pulses and diabetes.
2 studiesSoy foods in general; pulses in the cohort analysis.
Studies, doses and limits
What the trials found
We read the NCCIH statements and the 2019 umbrella review abstract, which found no association between pulses (with or without other legumes) and diabetes incidence (graded very low certainty). Underlying soy studies were not opened.
Results
Unclear and not tested with edamame.
Effect sizes as reported
No effect sizes read for soy and diabetes.
Why this rating
Insufficient: an agency statement that soy diets may lower risk, set against a pulse cohort analysis that found no link.
Form and dose studied
Soy foods in general; pulses in the cohort analysis.
Who was studied
Adults.
Limits
No soy-specific figures read. Not edamame.
Why researchers looked
Soy foods are slowly digested protein and fibre foods, so researchers ask about blood sugar.
Traditional use
Edamame are eaten steamed or boiled, in the pod or shelled, as a snack, side dish or in salads. Long use as food is not proof that it treats any condition.
Proposed mechanism Not established
Not established in the sources read.
A proposed mechanism does not show that the effect happens in people.
None specific.
Obesity (pulses, observational)
Very low certaintyIn follow-up studies, higher pulse intake went with less obesity (RR 0.87), graded very low certainty. Soybeans were not separated out.
1 studiesPulses and legumes as eaten.
Studies, doses and limits
What the trials found
A 2019 umbrella review of cohort studies found the highest pulse intake linked to obesity incidence RR 0.87 (95% CI 0.81 to 0.94), graded very low certainty.
Results
A small link that cannot show cause, for pulses in general.
Effect sizes as reported
Obesity incidence RR 0.87 (0.81 to 0.94).
Why this rating
Very low: observational and graded very low by the reviewers.
Form and dose studied
Pulses and legumes as eaten.
Who was studied
Adults in cohort studies.
Limits
Observational. Not edamame.
Why researchers looked
Pulses are filling foods with protein and fibre, so researchers ask about weight.
Traditional use
Edamame are eaten steamed or boiled, in the pod or shelled, as a snack, side dish or in salads. Long use as food is not proof that it treats any condition.
Proposed mechanism Not established
Not established.
A proposed mechanism does not show that the effect happens in people.
None specific.
Connections to the rest of health
How Edamame (Green Soybeans) connects to the rest of our health knowledge graph. Every link says what kind of connection it is. A safety link (for example to the liver) is a warning, not a benefit. A study that merely mentions a topic never creates a benefit link.
Explore every connection: goals, body systems, organs, symptoms, genes
A. Wellness goals
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Balanced Nutrition | High certainty | Plant protein, fibre and folate (nutrient content): Cooked, shelled edamame have 12.4 g of protein, 4.2 g of fibre and 111 micrograms of folate per 100 g, by USDA data. One cup (180 g) has about 22 g of protein, 7.6 g of fibre and 200 micrograms of folate. | 22 21 | |
| Cholesterol Balance | Demonstrated clinical effect | Moderate certainty | Cholesterol (soy protein in place of other protein): In pooled trials, soy protein in place of other protein lowered LDL ("bad") cholesterol by about 4.8 mg/dL (roughly 3 to 4%). The trials used soy protein in many forms, not edamame in particular. | 1 18 |
| Heart Health | Demonstrated clinical effect | Moderate certainty | Cholesterol (soy protein in place of other protein): In pooled trials, soy protein in place of other protein lowered LDL ("bad") cholesterol by about 4.8 mg/dL (roughly 3 to 4%). The trials used soy protein in many forms, not edamame in particular. | 1 18 |
| Heart Health | Low certainty | Heart disease (legumes, observational): People who ate the most legumes had slightly less heart disease in follow-up studies (about 6% less cardiovascular disease and 10% less coronary heart disease), but no difference in stroke. Soybeans were not separated out. | 5 10 | |
| Blood Pressure Support | Low certainty | Blood pressure: Pooled trials of soy protein supplements in postmenopausal women found a small fall in blood pressure (about 3 mmHg systolic), seen at 25 g a day of soy protein or more. Follow-up studies of pulses link higher intake to less high blood pressure (RR 0.91, very low certainty). | 3 10 18 | |
| Heart Health | Low certainty | Blood pressure: Pooled trials of soy protein supplements in postmenopausal women found a small fall in blood pressure (about 3 mmHg systolic), seen at 25 g a day of soy protein or more. Follow-up studies of pulses link higher intake to less high blood pressure (RR 0.91, very low certainty). | 3 10 18 | |
| Womens Wellness | Mixed findings | Menopause symptoms (isoflavones): A 2025 pooled analysis of isoflavone studies in perimenopausal women found a small overall symptom benefit, but no significant effect on hot flushes or sweating. NCCIH calls the effect on hot flashes small and not completely consistent. | 4 18 12 | |
| Menopause Support | Mixed findings | Menopause symptoms (isoflavones): A 2025 pooled analysis of isoflavone studies in perimenopausal women found a small overall symptom benefit, but no significant effect on hot flushes or sweating. NCCIH calls the effect on hot flashes small and not completely consistent. | 4 18 12 | |
| Womens Wellness | Low certainty | Breast cancer risk and survival (soy, observational): In follow-up studies, higher soy intake before a breast cancer diagnosis went with slightly better overall survival; intake after diagnosis was not significantly linked. A large Chinese cohort found no link between moderate soy intake and getting breast cancer. | 7 11 18 | |
| Healthy Aging | Low certainty | Living longer (soy, observational): In follow-up studies, higher soy intake was linked to fewer deaths from cancer (RR 0.88) and from cardiovascular disease (RR 0.85). Soy protein alone was not significantly linked to all-cause or cardiovascular deaths. | 6 | |
| Mens Wellness | Demonstrated clinical effect | Moderate certainty | Male hormones (a concern, no effect found): A 2021 pooled analysis of 41 clinical studies found that soy protein or isoflavone intake did not change testosterone, estradiol or estrone in men, whatever the dose or study length. | 8 |
| Healthy Aging | Low certainty | Bone density after menopause (agency summary): NCCIH says soy isoflavones probably have a beneficial effect on bone density in postmenopausal women. | 18 | |
| Blood Sugar Balance | Not enough evidence | Type 2 diabetes risk and blood sugar (agency summary): NCCIH says people who eat diets high in soy may have a lower risk of type 2 diabetes, and that it is uncertain whether soy products improve blood sugar control in people who already have it. A pulse analysis of cohort studies found no link between pulses and diabetes. | 18 10 | |
| Weight Management | Very low certainty | Obesity (pulses, observational): In follow-up studies, higher pulse intake went with less obesity (RR 0.87), graded very low certainty. Soybeans were not separated out. | 10 |
B. Body systems
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Nutrition | Biological association | High certainty | Studied for: Plant protein, fibre and folate (nutrient content) | 22 21 |
| Cardiovascular System | Biological association | Moderate certainty | Studied for: Cholesterol (soy protein in place of other protein) Studied for: Heart disease (legumes, observational) | 1 18 5 10 3 |
| Endocrine System | Biological association | Mixed findings | Studied for: Menopause symptoms (isoflavones) Studied for: Breast cancer risk and survival (soy, observational) | 4 18 12 7 11 8 |
| Whole Body | Biological association | Low certainty | Studied for: Living longer (soy, observational) | 6 |
| Musculoskeletal System | Biological association | Low certainty | Studied for: Bone density after menopause (agency summary) | 18 |
| Metabolism Weight | Biological association | Not enough evidence | Studied for: Type 2 diabetes risk and blood sugar (agency summary) Studied for: Obesity (pulses, observational) | 18 10 |
E. Health conditions
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Food allergy | Adverse effect or risk | Documented risk | Soybeans are a major food allergen named by the US FDA; pooled European estimates give 0.5% self-reported and 0.3% challenge-verified soy allergy. Preparation or compound: Soy protein in edamame |
13 15 9 |
| High cholesterol | Small effect for soy protein, not edamame | Soy protein in place of other protein lowered LDL by about 4.8 mg/dL in pooled trials. Preparation or compound: Soy protein |
1 |
I. Biomarkers
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| LDL cholesterol | Biological association | Moderate certainty | Measured in trials: lowered slightly. A lab change is not the same as a health benefit. | 1 18 |
| Total cholesterol | Biological association | Moderate certainty | Measured in trials: lowered slightly. A lab change is not the same as a health benefit. | 1 |
| Systolic blood pressure | Biological association | Low certainty | Measured in trials: lowered slightly. A lab change is not the same as a health benefit. | 3 |
| Diastolic blood pressure | Biological association | Low certainty | Measured in trials: lowered slightly. A lab change is not the same as a health benefit. | 3 |
| Total testosterone (men) | Biological association | Moderate certainty | Measured in trials: no-change. A lab change is not the same as a health benefit. | 8 |
| Estradiol (men) | Biological association | Moderate certainty | Measured in trials: no-change. A lab change is not the same as a health benefit. | 8 |
| Menopausal symptom score | Biological association | Mixed findings | Measured in trials: lowered slightly. A lab change is not the same as a health benefit. | 4 |
K. Biological pathways
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Plant protein | Preliminary mechanism | Human | Edamame are a protein-rich legume; soy protein in place of other protein lowers LDL slightly. | 22 1 |
| Isoflavones | Preliminary mechanism | In vitro | Estrogen-like plant compounds; lower in edamame varieties than in tofu varieties in one laboratory study. | 12 18 |
| Potassium | Preliminary mechanism | Human | Edamame contain potassium; relevant to kidney diets. | 16 22 |
| Vitamin K | Preliminary mechanism | Human | Frozen edamame contain vitamin K; relevant to warfarin users. | 21 17 |
L. Active compounds
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Plant protein | Biological association | Human | Soy is a protein-rich legume; NCCIH says soy protein in place of other proteins may lower cholesterol to a small extent. Preparation or compound: Seed |
22 21 18 1 |
| Dietary fibre | Biological association | Composition | A fibre food; the soluble and insoluble split was not read. Preparation or compound: Seed |
22 21 |
| Folate | Biological association | Composition | A B vitamin; content only, no trial of edamame read. Preparation or compound: Seed |
22 21 |
| Isoflavones (daidzein, genistein, glycitein) | Biological association | In vitro | NCCIH describes isoflavones as compounds similar in structure to the hormone estrogen. Laboratory chemistry does not show what edamame do in the body. Preparation or compound: Seed |
12 18 |
| Potassium | Biological association | Composition | Relevant to people on a potassium limit. Preparation or compound: Seed |
22 21 16 |
| Vitamin K (phylloquinone) | Biological association | Composition | Relevant to people on warfarin. Preparation or compound: Seed |
21 17 |
Each connection is stored with the ingredient, the connected record, the kind of connection, the evidence status, the supporting studies, the preparation or compound involved, and a review date (last reviewed October 26, 2026).
The evidence
The research centre for Edamame (Green Soybeans). Every record here was checked against PubMed or the publisher's page; we never list a study we have not verified.
Evidence by outcome
Bars show how many studies we found for each outcome, not how well it works. People are added up across trials only (reviews are not added, to avoid double counting).
How we rate evidence
High certainty
Several well-run trials or reviews agree; further research is unlikely to change the picture much.
Moderate certainty
Good trials point the same way, but some doubt remains.
Low certainty
Small, short or inconsistent trials. The finding could change with better research.
Very low certainty
Very little or very weak human data. Treat as a possibility only.
Mixed findings
Trials or reviews disagree with each other.
Not enough evidence
Not enough human research to say either way.
Evidence against
Good research found no benefit, or found harm.
We take the reviewers' own risk-of-bias and GRADE statements where they exist, and otherwise judge from study size, design, consistency, directness and whether a product matches what is sold. Many publications do not make evidence high. Method note: We started from our existing edamame summary, re-checked nutrition against USDA FoodData Central data, read the NCCIH, FDA, MedlinePlus, NHS and NIDDK pages and re-read PubMed abstracts for reviews and trials. Only abstracts were read for studies. Items we could not verify are flagged in the research gaps.
Study library: every study we checked 23
| Study | Design | People | Product, dose, length | Result |
|---|---|---|---|---|
| Blanco Mejia 2019 A Meta-Analysis of 46 Studies Identified by the FDA Demonstrates that Soy Protein Decreases Circulating LDL and Total Cholesterol Concentrations in Adults. J Nutr · PMID 31006811 · DOI |
Systematic review meta analysis |
Adults with baseline LDL 110 to 201 mg/dL; 41 trials gave LDL data (43 trials in all, from 46 identified by the US FDA) | Soy protein compared with non-soy protein Soy protein (not edamame) Median 25 g a day (trial detail, not advice) Median 6 weeks · vs Non-soy protein |
Soy protein lowered LDL cholesterol and total cholesterol compared with non-soy protein. About 75% of individual trials showed an LDL fall, but only a minority were individually significant. The authors put the average LDL fall at about 3 to 4%. LDL -4.76 mg/dL; total cholesterol -6.41 mg/dL (LDL -6.71 to -2.80 mg/dL (I2 = 55%); total cholesterol -9.30 to -3.52 mg/dL (I2 = 74%)) Methods, limits and fundingOutcomes: LDL cholesterol, total cholesterol Limitations: Soy protein in many forms, not edamame. Trials were short. A small average change. No dose-response effect was found. Funding and conflicts: Registered NCT03468127. Funding is not stated in the abstract. One author is affiliated with the Soy Nutrition Institute, so the review has an industry-linked author. Registration: NCT03468127 Read: abstract |
| Gatta 2023 Interference or Noninterference Between Soy and Levothyroxine: That Is the Question. A Narrative Review of Literature. Endocr Pract · PMID 37633413 · DOI |
Narrative review |
Case reports, case series and a few trials | Soy products and soy isoflavones taken near levothyroxine (thyroid hormone tablets and liquid) Soy products and isoflavone preparations Studies to November 2022 · vs Levothyroxine taken without soy |
The few data, mainly case reports, hint that soy products may interfere with levothyroxine tablets. The only prospective randomised crossover study found no difference when soy isoflavones and levothyroxine were taken together. Data on liquid forms were too scarce to conclude. The authors judged any effect likely small in practice. No pooled effect; case reports against one crossover trial with no difference (Not applicable) Methods, limits and fundingOutcomes: Absorption of levothyroxine Limitations: A narrative review, not a systematic one. Mostly case reports. Edamame as food was not named in the abstract. Funding and conflicts: The authors declared no interests. Read: abstract |
| Kou 2017 Effect of soybean protein on blood pressure in postmenopausal women: a meta-analysis of randomized controlled trials. Food Funct · PMID 28675204 · DOI |
Systematic review meta analysis |
1551 12 randomised trials in postmenopausal women |
Soy protein supplementation (some trials of isoflavones) Soy protein as a supplement, not edamame Subgroup that worked: 25 g a day or more of soy protein (trial detail, not advice) Not given in the abstract · vs Control without soy protein |
Soy protein lowered blood pressure a little on average. The fall was only seen at 25 g a day of soy protein or more (or 100 mg a day of isoflavones or more); lower amounts showed no effect. Systolic -3.03 mmHg; diastolic -0.71 mmHg (25 g a day or more: systolic -4.62, diastolic -1.63) (Systolic -5.03 to -1.02; diastolic -1.26 to -0.16) Methods, limits and fundingOutcomes: Systolic and diastolic blood pressure Limitations: Postmenopausal women only. Soy protein supplements, not whole edamame. The authors say more high-quality trials are needed. Funding and conflicts: Funding is not stated in the abstract. Read: abstract |
| Luan 2025 Effects of soy isoflavones on menopausal symptoms in perimenopausal women: a systematic review and meta-analysis. PeerJ · PMID 40718787 · DOI |
Systematic review meta analysis |
12 studies of perimenopausal women (7 studies, 533 women, for the overall symptom score) | Soy isoflavone preparations Isoflavone supplements (not edamame) Not given in the abstract Not given in the abstract · vs Comparison groups in each trial |
Isoflavones gave a small overall improvement in menopausal symptoms and in headache, psychosocial symptoms, palpitation and depression scores. There was no significant effect on hot flushes, excessive sweating, insomnia or vasomotor symptoms. The authors warn the studies were small. Overall symptoms Hedges g -0.25; depression g -0.72; hot flushes: no significant effect (Overall -0.42 to -0.08) Methods, limits and fundingOutcomes: Menopausal symptom scores, including hot flushes and sweating Limitations: Small studies and few participants. Supplements, not food. Hot flushes, the main symptom people ask about, showed no significant effect. Funding and conflicts: No competing interests declared. Read: abstract |
| Mendes 2023 Intake of legumes and cardiovascular disease: A systematic review and dose-response meta-analysis. Nutr Metab Cardiovasc Dis · PMID 36411221 · DOI |
Systematic review meta analysis |
26 observational studies (21 prospective cohorts, 5 case-control) | Higher versus lower legume intake Legumes as a group (soybeans not analysed separately in the abstract) Dose-response analysis: benefit levelled off at about 400 g a week (an observation, not advice) Cohort follow-up · vs Lowest intake group |
Highest legume intake was linked to a little less cardiovascular disease and coronary heart disease, and no difference for stroke. CVD RR 0.94; coronary heart disease RR 0.90; stroke RR 1.00 (CVD 0.89 to 0.99; CHD 0.85 to 0.96; stroke 0.93 to 1.08) Methods, limits and fundingOutcomes: Cardiovascular disease, coronary heart disease, stroke Limitations: Observational, so it shows association, not cause. Legumes as a group, not edamame or soy alone. Funding and conflicts: No competing interests declared. Registration: PROSPERO CRD42021247565 Read: abstract |
| Nachvak 2019 Soy, Soy Isoflavones, and Protein Intake in Relation to Mortality from All Causes, Cancers, and Cardiovascular Diseases: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies. J Acad Nutr Diet · PMID 31278047 · DOI |
Systematic review meta analysis |
330826 23 prospective cohort studies (330,826 people) |
Higher versus lower intake of soy, soy isoflavones and soy protein Soy foods and nutrients as eaten (not edamame specifically) Highest versus lowest intake; dose-response by 10 mg a day of isoflavones or 5 g a day of soy protein Cohort follow-up · vs Lowest intake group |
Higher soy intake was linked to lower deaths from cancer and from cardiovascular disease. Soy protein alone was not significantly linked to all-cause or cardiovascular deaths. The highest isoflavone intake group had 10% lower all-cause mortality. Cancer deaths RR 0.88; cardiovascular deaths 0.85 for soy and soy products; all-cause mortality 10% lower for highest isoflavone intake (Cancer deaths 0.79 to 0.99; cardiovascular deaths 0.72 to 0.99) Methods, limits and fundingOutcomes: Death from any cause, cancer and cardiovascular disease Limitations: Observational, so no proof of cause. People who eat more soy may differ in other ways. Soy in general, not edamame. Funding and conflicts: Funding is not stated in the abstract. Read: abstract |
| Qiu 2019 Soy and isoflavones consumption and breast cancer survival and recurrence: a systematic review and meta-analysis. Eur J Nutr · PMID 30382332 · DOI |
Systematic review meta analysis |
37275 12 articles on women with breast cancer (37,275 women) |
Soy and isoflavone consumption before or after a breast cancer diagnosis Soy foods and isoflavones as eaten (not edamame specifically) Highest versus lowest intake Observational follow-up · vs Lowest intake group |
Before diagnosis, higher soy intake was linked to slightly better overall survival (more clearly in postmenopausal women) but not clearly to breast cancer-specific survival. After diagnosis, the links with survival were not significant. Both were linked to lower recurrence. The authors call the evidence limited. Pre-diagnosis overall survival HR 0.84; pre-diagnosis breast cancer-specific survival HR 0.89 (not significant); post-diagnosis overall survival HR 0.80 (not significant) (Pre-diagnosis overall survival 0.71 to 0.98; breast cancer-specific 0.74 to 1.07; post-diagnosis overall survival 0.62 to 1.04) Methods, limits and fundingOutcomes: Overall survival, breast cancer-specific survival, recurrence Limitations: Observational. Studies only to January 2018. Soy in general, not edamame. Funding and conflicts: Funding is not stated in the abstract. Read: abstract |
| Reed 2021 Neither soy nor isoflavone intake affects male reproductive hormones: An expanded and updated meta-analysis of clinical studies. Reprod Toxicol · PMID 33383165 · DOI |
Systematic review meta analysis |
1753 41 clinical studies in adult men (total testosterone measured in 1,753 men) |
Soy foods, soy protein or isoflavone extracts Soy foods, soy protein and isoflavone extracts No effect found at any isoflavone dose No effect found at any study length · vs Control groups in each study |
Across the clinical studies, soy protein or isoflavone intake did not significantly change total testosterone, free testosterone, estradiol or estrone in men, whatever the dose or study length. No significant effect on any outcome measured (Not given in the abstract) Methods, limits and fundingOutcomes: Total and free testosterone, estradiol, estrone, sex hormone binding globulin Limitations: Hormone levels, not fertility or other outcomes. Includes soy protein and extracts as well as foods. Not edamame specifically. Funding and conflicts: Funding is not stated in the abstract. One author is affiliated with Nutrition Matters, Inc. Read: abstract |
| Spolidoro 2023 Prevalence estimates of eight big food allergies in Europe: Updated systematic review and meta-analysis. Allergy · PMID 37405695 · DOI |
Systematic review meta analysis |
93 studies from Europe, all ages | Food allergy prevalence for eight foods including soy Soy (all forms) Studies from 2000 to 2021 |
Pooled lifetime self-reported soy allergy was 0.5%; food-challenge-verified soy allergy was 0.3%. Both were lower than cow milk, egg and peanut figures. Soy self-reported lifetime prevalence 0.5%; challenge-verified 0.3% (Self-reported 0.3 to 0.7%; challenge-verified 0.1 to 0.4%) Methods, limits and fundingOutcomes: Self-reported and food-challenge-verified prevalence Limitations: Europe only; mostly moderate risk of bias; soy in general, not edamame. Prevalence in other regions may differ. Funding and conflicts: Registered PROSPERO CRD42021266657. Funding is not stated in the abstract. Registration: PROSPERO CRD42021266657 Read: abstract |
| Viguiliouk 2019 Associations between Dietary Pulses Alone or with Other Legumes and Cardiometabolic Disease Outcomes: An Umbrella Review and Updated Systematic Review and Meta-analysis of Prospective Cohort Studies. Adv Nutr · PMID 31728500 · DOI |
Umbrella review and cohort meta analysis |
28 unique prospective cohort studies, with 83,284 hypertension cases and 8,125 obesity cases among the outcomes | Higher versus lower intake of dietary pulses, with or without other legumes Pulses and legumes as food (soybeans not analysed separately in the abstract) Not given in the abstract Cohort follow-up · vs Lowest intake group |
Higher pulse intake went with less cardiovascular disease, coronary heart disease, high blood pressure and obesity, but not with heart attack, stroke or diabetes. Certainty was graded low for CVD and very low for the rest. CVD RR 0.92; CHD 0.90; hypertension 0.91; obesity 0.87; no association with MI, stroke or diabetes (CVD 0.85 to 0.99; CHD 0.83 to 0.99; hypertension 0.86 to 0.97; obesity 0.81 to 0.94) Methods, limits and fundingOutcomes: Cardiovascular disease, coronary heart disease, hypertension, obesity, diabetes, stroke Limitations: Observational. GRADE low for CVD and very low for CHD, hypertension and obesity. Pulses and legumes as a group. Funding and conflicts: Registered NCT03555734. Funding is not stated in the abstract. Registration: NCT03555734 Read: abstract |
| Wei 2020 Soy intake and breast cancer risk: a prospective study of 300,000 Chinese women and a dose-response meta-analysis. Eur J Epidemiol · PMID 31754945 · DOI |
Cohort and dose response meta analysis |
300000 Over 300,000 Chinese women aged 30 to 79 (China Kadoorie Biobank) followed about 10 years; 2,289 developed breast cancer; plus a meta-analysis of prospective studies |
Habitual soy intake from food, measured as soy isoflavones Soy foods as eaten Mean intake 9.4 mg of isoflavones a day; top quarter about 19.1 mg a day versus bottom quarter 4.5 mg a day (study detail, not advice) 10 years of follow-up · vs Lowest intake quarter |
In the large Chinese cohort, moderate soy intake was not linked to breast cancer risk (RR 1.00). In the meta-analysis of prospective studies, each extra 10 mg a day of isoflavones was linked to 3% lower risk. Cohort top versus bottom quarter RR 1.00; meta-analysis 3% lower risk per 10 mg a day (Cohort 0.81 to 1.22; meta-analysis 1% to 5% lower) Methods, limits and fundingOutcomes: Breast cancer risk Limitations: Observational, so no proof of cause. Soy foods in general. Intake in the cohort was moderate. Funding and conflicts: No conflicts of interest declared. Read: abstract |
| Wu 2004 LC/UV/ESI-MS analysis of isoflavones in Edamame and Tofu soybeans. J Agric Food Chem · PMID 15137811 · DOI |
Laboratory analysis n/a |
30 soybean varieties (edamame types and tofu types) | Chemical analysis of isoflavones Soybean seeds: immature (edamame) and mature (tofu) varieties |
Total isoflavones ranged from 0.02 to 0.12% in the edamame varieties, which are harvested while the seeds are immature, and from 0.16 to 0.25% in the tofu varieties, harvested when the seeds are mature. Edamame varieties 0.02 to 0.12% total isoflavones; tofu varieties 0.16 to 0.25% (Not applicable) Methods, limits and fundingOutcomes: Total isoflavones (as aglycones: daidzein, genistein, glycitein) Limitations: Laboratory chemistry of 30 varieties. It does not tell us what edamame does in the body. Published in 2004; US varieties tested. Funding and conflicts: The PubMed record lists US government and non-US government research support. Read: abstract |
| s-fda-allergens U.S. FDA: Food Allergies · Source |
Regulator n/a |
Methods, limits and fundingRead: full-text | ||
| s-gbif-glycine-max GBIF Backbone: Glycine max (L.) Merr. (usageKey 5359660) · Source |
Reference database n/a |
Methods, limits and fundingRead: full-text | ||
| s-medlineplus-foodallergy MedlinePlus: Food allergy · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-medlineplus-potassium MedlinePlus: Potassium in diet · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-medlineplus-vitk MedlinePlus: Vitamin K in diet · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-nccih-soy NCCIH: Soy: Usefulness and Safety · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-nhs-5aday NHS: 5 A Day, what counts? · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-niddk-gas NIDDK: Eating, Diet, and Nutrition for Gas in the Digestive Tract · Source |
Health agency n/a |
Methods, limits and fundingRead: full-text | ||
| s-usda-fdc-168410 USDA FoodData Central: Edamame, frozen, unprepared (FDC 168410) · Source |
Reference database n/a |
Methods, limits and fundingRead: full-text | ||
| s-usda-fdc-169283 USDA FoodData Central: Soybeans, green, cooked, boiled, drained, without salt (FDC 169283) · Source |
Reference database n/a |
Methods, limits and fundingRead: full-text | ||
| s-usda-fdc-174270 USDA FoodData Central: Soybeans, mature seeds, raw (FDC 174270) · Source |
Reference database n/a |
Methods, limits and fundingRead: full-text |
What we do not know yet
- No trial that fed people edamame was found for cholesterol, blood pressure, blood sugar, menopause, cancer or heart disease; the trials used soy protein or isoflavone supplements.
- The follow-up studies cover soy or legumes as a group; an edamame-only result was not in the abstracts read.
- Bone density and type 2 diabetes are summarised only from the NCCIH page; the studies behind it were not opened.
- FODMAP rating, choking risk for young children, infant feeding, raw soybean toxins, oxalate, purines, pesticide residues, heavy metals and Listeria on frozen edamame were not researched.
How new research is added
New studies are found by a saved PubMed search and placed in a review queue before the page changes.
Lab markers
What changed in blood or saliva tests during trials. A changed number is not the same as feeling or being healthier, and we give no "normal ranges".
Hormonal 1
Estradiol (men)
No clear change in trials
The main form of estrogen, measured in the blood.
Moderate certaintyResults and what it means
Why it was measured
Because isoflavones resemble estrogen, researchers checked whether estrogen rose.
Statistical vs. clinical meaning
No change in blood estrogen was found in men.
Safety implication
None found.
| Study | Result | People | Product |
|---|---|---|---|
| 8 | No significant effect of soy protein or isoflavones on estradiol or estrone | 1,000 men for estradiol; 239 for estrone | Soy foods, soy protein or isoflavone extracts |
Metabolic 2
LDL cholesterol
Lowered slightly in trials
The 'bad' cholesterol carried in the blood. Higher levels are linked to more heart disease.
Moderate certaintyResults and what it means
Why it was measured
It is the usual blood marker used in diet trials for heart risk.
Statistical vs. clinical meaning
A small average fall for soy protein in place of other protein. Not tested with edamame.
Safety implication
None specific.
| Study | Result | People | Product |
|---|---|---|---|
| 1 | LDL -4.76 mg/dL (95% CI -6.71 to -2.80), about 3 to 4% | Adults in 41 trials with LDL data | Soy protein (median 25 g a day) versus non-soy protein, median 6 weeks |
Total cholesterol
Lowered slightly in trials
All the cholesterol carried in the blood.
Moderate certaintyResults and what it means
Why it was measured
A routine blood test used as a rough guide to heart risk.
Statistical vs. clinical meaning
A small average fall; large spread between trials (I2 74%).
Safety implication
None specific.
| Study | Result | People | Product |
|---|---|---|---|
| 1 | Total cholesterol -6.41 mg/dL (95% CI -9.30 to -3.52) | Adults in 43 trials | Soy protein (median 25 g a day) versus non-soy protein, median 6 weeks |
Other 4
Systolic blood pressure
Lowered slightly in trials
The top number of a blood pressure reading, the pressure when the heart beats.
Low certaintyResults and what it means
Why it was measured
High blood pressure raises the risk of heart attack and stroke.
Statistical vs. clinical meaning
A small change in one group of women, with supplement-sized amounts of soy protein.
Safety implication
People on blood pressure medicine should ask their clinician before big diet changes.
| Study | Result | People | Product |
|---|---|---|---|
| 3 | Systolic -3.03 mmHg (95% CI -5.03 to -1.02); -4.62 mmHg at 25 g a day or more of soy protein | 1,551 postmenopausal women in 12 trials | Soy protein supplements versus controls |
Diastolic blood pressure
Lowered slightly in trials
The bottom number of a blood pressure reading, the pressure between beats.
Low certaintyResults and what it means
Why it was measured
Used with systolic pressure to judge blood pressure.
Statistical vs. clinical meaning
A very small change.
Safety implication
None specific.
| Study | Result | People | Product |
|---|---|---|---|
| 3 | Diastolic -0.71 mmHg (95% CI -1.26 to -0.16); -1.63 mmHg at 25 g a day or more | 1,551 postmenopausal women in 12 trials | Soy protein supplements versus controls |
Total testosterone (men)
No clear change in trials
The main male sex hormone measured in the blood.
Moderate certaintyResults and what it means
Why it was measured
Used to check whether soy changes male hormone levels.
Statistical vs. clinical meaning
No change in blood hormone levels was found.
Safety implication
Reassuring for hormone levels; fertility was not assessed.
| Study | Result | People | Product |
|---|---|---|---|
| 8 | No significant effect of soy protein or isoflavones on total testosterone | 1,753 men in the analysis | Soy foods, soy protein or isoflavone extracts, any dose or duration |
Menopausal symptom score
Lowered slightly in trials
A questionnaire score of menopause symptoms such as headache, mood and palpitations.
Mixed findingsResults and what it means
Why it was measured
It is how trials judge whether symptoms improve.
Statistical vs. clinical meaning
A small overall improvement, but no significant effect on hot flushes.
Safety implication
Supplements are concentrated; ask a clinician.
| Study | Result | People | Product |
|---|---|---|---|
| 4 | Overall symptoms Hedges g -0.25 (95% CI -0.42 to -0.08); hot flushes and sweating not significantly changed | 533 women in 7 studies | Soy isoflavone preparations |
Safety
What studies and official sources say about side effects, medicines and who should check first. Each point shows what kind of evidence it comes from.
Main points to know 5
- Soy allergy is real and can be severe. Soybeans are one of the nine major food allergens named by the US FDA, and MedlinePlus lists soy among common food allergies, mostly in children. In Europe, pooled studies put self-reported lifetime soy allergy at 0.5% and food-challenge-verified soy allergy at 0.3%. For wheezing, trouble breathing, swelling of the face, lips or throat, or any serious whole-body reaction after eating, call 911 or your local emergency number. Edamame are soybeans, so they are not safe for someone with soy allergy. Authoritative guidance 13 15 9
- Soy and thyroid tablets (levothyroxine). A 2023 review found a few case reports of soy products interfering with levothyroxine tablets, one randomised crossover study with no difference, and too little data on liquid forms. The authors judged any effect likely small in practice. If you take thyroid medicine, ask your prescriber or pharmacist about timing; do not change a medicine on your own. Narrative review 2
- Pregnancy and breastfeeding. NCCIH says soy in amounts greater than those commonly found in foods may be unsafe in pregnancy, and that little is known about larger amounts while breastfeeding. That caution is about supplement-sized or concentrated soy rather than edamame as an ordinary food. Ask your doctor or midwife. Authoritative guidance 18
- Gas, bloating and other digestive effects. NCCIH lists bloating, constipation, diarrhea and nausea as possible side effects of soy. NIDDK says bacteria break down some carbohydrates and make gas, and lists legumes (beans, peas and lentils) among foods that may lead to excess gas. Edamame are not named by NIDDK. Authoritative guidance 18 20
- Kidney disease: potassium. USDA lists 539 mg of potassium per 100 g of boiled, shelled green soybeans. MedlinePlus says people with kidney problems, particularly those on dialysis, should not eat too many potassium-rich foods and names soy among vegetable sources. Ask your kidney team or dietitian. Authoritative guidance 22 16
Side effects 2
| Effect | How often | Severity and recovery | Evidence |
|---|---|---|---|
| Allergic reactions to soy, from itching and hives to anaphylaxis Prevalence figures are for soy in general and for Europe, not for edamame or other regions. | Europe, all ages: 0.5% self-reported lifetime and 0.3% food-challenge-verified (pooled estimates); 93 studies | can be severe (anaphylaxis) Not given in the sources read. | Systematic review 9 13 15 |
| Bloating, constipation, diarrhea, nausea NCCIH lists these as possible side effects of soy. | Not given | mild to moderate Not given in the sources read. | Authoritative guidance 18 20 |
Liver
No liver injury from eating edamame was found in the sources read. A liver-safety source such as LiverTox was not searched for a food.
How often. No frequency was found.
Monitoring. No agency monitoring advice was found.
This is a safety connection. It is not evidence that Edamame (Green Soybeans) supports liver health.
Medicines and supplements 3
| With | Why it matters | Importance | Evidence | What to do |
|---|---|---|---|---|
| Levothyroxine (thyroid hormone tablets) prescription | Possible reduced absorption of the tablet when taken with soy products; not established. | A narrative review found mainly case reports, one randomised crossover study with no difference, and too little data on liquid forms. The authors thought any effect likely has little clinical impact. Edamame as food were not named in the abstract. | Case reports and review Low certainty 2 | Ask your prescriber or pharmacist about timing. Do not change a medicine on your own. |
| Monoamine oxidase inhibitors (MAOI antidepressants) prescription | NCCIH says interactions have been reported with soy products that contain a lot of tyramine, such as tofu and soy sauce, causing dangerously high blood pressure. | NCCIH names tofu and soy sauce, not edamame. The tyramine level of edamame was not found in the sources read. | Authoritative guidance Not enough evidence 18 | If you take an MAOI, ask your pharmacist about edamame before eating them regularly. |
| Warfarin (blood thinner) and vitamin K prescription | Vitamin K in food can change how warfarin works; MedlinePlus says to keep vitamin K steady from day to day. | USDA lists 31.4 micrograms of vitamin K per 100 g of frozen, unprepared edamame and no vitamin K value for the boiled item. MedlinePlus does not name soybeans on its page. We read no study of edamame and warfarin. | Theoretical Not enough evidence 17 21 | Ask your care team before adding edamame regularly if you take warfarin. |
Who should check first 2
| Situation | Advice | Evidence |
|---|---|---|
| Known or suspected soy allergy | Avoid edamame and other soy foods unless an allergist has said otherwise. Read labels: US law requires soy to be named on packaged foods. For trouble breathing or swelling of the face or throat, call emergency services. | Authoritative guidance 13 15 |
| Kidney disease with a potassium limit, especially on dialysis | Ask your kidney team or dietitian how edamame fit your limits. | Authoritative guidance 16 22 |
Overdose, product quality and regulators
Summary. No toxicity from steamed or boiled edamame as ordinary food was found in the sources read. Raw or undercooked bean toxins (such as lectins) and trypsin inhibitors were not researched, so no statement is made about eating edamame raw. Follow the package heating directions.
Animal. Not reviewed.
Human doses studied. NCCIH says soy protein supplements have been used safely in research for up to 16 weeks and concentrated isoflavone extracts for up to 6 months. These are supplements, not edamame.
Overdose response. Not found.
Genotoxicity. Not researched.
Toxic or hazardous parts. Not researched for soybeans. Edamame are the green bean eaten from the pod; the pod itself is usually not eaten.
No contamination study of edamame (pesticides, heavy metals, mould or Listeria on frozen vegetables) was read for this page.
| Body | Action | Date |
|---|---|---|
| U.S. FDA (United States) | Names soybeans among the nine major food allergens; packaged foods must name the food source of a major allergen on the label. source | Page read 2026-10-26 (date not shown) |
| NCCIH (US National Institutes of Health) (United States) | Soy in amounts greater than those commonly found in foods may be unsafe in pregnancy; little is known about larger amounts while breastfeeding; MAOI interaction reports for high-tyramine soy products (tofu, soy sauce); side effects may include bloating, constipation, diarrhea, nausea. source | Page read 2026-10-26 (date not shown) |
| MedlinePlus (US National Library of Medicine) (United States) | Food allergy: call 911 or the local emergency number for serious or whole-body reactions, particularly wheezing or difficulty breathing; use prescribed epinephrine as soon as possible. source | Review date 2024-10-29 |
When to get medical help
- Wheezing, trouble breathing, swelling of the lips, face or throat, widespread hives, repeated vomiting or collapse after eating edamame (possible anaphylaxis): use prescribed epinephrine as directed and call 911 or your local emergency number
- Any serious or whole-body reaction after eating a food: call 911 or your local emergency number
Stop using the product and contact a clinician or emergency service. In the US, Poison Control is 1-800-222-1222.
General information only, not medical advice. Ask a clinician or pharmacist before use, especially with medicines, in pregnancy or with a health condition. See the Natural Remedy Safety guide.
Frequently asked questions
What are edamame good for?
Do edamame lower cholesterol?
Are edamame good for the heart or blood pressure?
Can you be allergic to edamame?
Are edamame the same as tofu, soy milk or soy supplements?
Do the isoflavones in edamame act like estrogen?
Does soy raise or lower breast cancer risk?
Observational studies are mixed and limited. Soy intake before diagnosis was linked to slightly better overall survival, and a large Chinese cohort found no link between moderate soy intake and getting breast cancer. NCCIH says soy supplements have not been shown to reduce risk. People with breast cancer should ask their oncology team.
Do edamame help with menopause symptoms?
Can I eat edamame if I take thyroid medicine?
Ask your prescriber or pharmacist. A 2023 review found a few case reports of soy affecting levothyroxine tablets, one crossover study with no difference, and too little data on liquid forms. The authors thought any effect was likely small.
Are edamame safe in pregnancy and breastfeeding?
NCCIH says soy in amounts greater than those commonly found in foods may be unsafe in pregnancy, and little is known about larger amounts while breastfeeding. No edamame-specific warning was found. Ask your doctor or midwife.
Do edamame cause gas?
Explore by health goal
Heart HealthWomens WellnessHealthy AgingBalanced NutritionCholesterol BalanceBlood Pressure SupportMenopause SupportMens WellnessBlood Sugar BalanceWeight Management
Editorial transparency
- Written by
- AlternativeMed editorial team. Research compiled with AI assistance, then checked against the sources listed.
- Medical review
- None. This page has not been reviewed by a physician or pharmacist.
- First published
- 2026-10-26
- Last substantive update
- 2026-10-26
- How we research
- We started from our existing edamame summary, re-checked nutrition against USDA FoodData Central data, read the NCCIH, FDA, MedlinePlus, NHS and NIDDK pages and re-read PubMed abstracts for reviews and trials. Only abstracts were read for studies. Items we could not verify are flagged in the research gaps.
- How we rate evidence
- See "How we rate evidence" in the Evidence tab.
- Independence
- No product is promoted on this page. No affiliate links are shown.
Sources 23
Each source was opened and checked. Where we read only the abstract, it says so. The small numbers in the text point here.
- Blanco Mejia S, Messina M, Li SS, et al.. A Meta-Analysis of 46 Studies Identified by the FDA Demonstrates that Soy Protein Decreases Circulating LDL and Total Cholesterol Concentrations in Adults.. J Nutr. 2019. PMID 31006811. DOI 10.1093/jn/nxz020. (abstract)
- Gatta E, Maltese V, Cavadini M, et al.. Interference or Noninterference Between Soy and Levothyroxine: That Is the Question. A Narrative Review of Literature.. Endocr Pract. 2023. PMID 37633413. DOI 10.1016/j.eprac.2023.08.009. (abstract)
- Kou T, Wang Q, Cai J, et al.. Effect of soybean protein on blood pressure in postmenopausal women: a meta-analysis of randomized controlled trials.. Food Funct. 2017. PMID 28675204. DOI 10.1039/c6fo01845a. (abstract)
- Luan H, Liu Q, Guo Y, et al.. Effects of soy isoflavones on menopausal symptoms in perimenopausal women: a systematic review and meta-analysis.. PeerJ. 2025. PMID 40718787. DOI 10.7717/peerj.19715. (abstract)
- Mendes V, Niforou A, Kasdagli MI, et al.. Intake of legumes and cardiovascular disease: A systematic review and dose-response meta-analysis.. Nutr Metab Cardiovasc Dis. 2023. PMID 36411221. DOI 10.1016/j.numecd.2022.10.006. (abstract)
- Nachvak SM, Moradi S, Anjom-Shoae J, et al.. Soy, Soy Isoflavones, and Protein Intake in Relation to Mortality from All Causes, Cancers, and Cardiovascular Diseases: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies.. J Acad Nutr Diet. 2019. PMID 31278047. DOI 10.1016/j.jand.2019.04.011. (abstract)
- Qiu S, Jiang C. Soy and isoflavones consumption and breast cancer survival and recurrence: a systematic review and meta-analysis.. Eur J Nutr. 2019. PMID 30382332. DOI 10.1007/s00394-018-1853-4. (abstract)
- Reed KE, Camargo J, Hamilton-Reeves J, et al.. Neither soy nor isoflavone intake affects male reproductive hormones: An expanded and updated meta-analysis of clinical studies.. Reprod Toxicol. 2021. PMID 33383165. DOI 10.1016/j.reprotox.2020.12.019. (abstract)
- Spolidoro GCI, Ali MM, Amera YT, et al.. Prevalence estimates of eight big food allergies in Europe: Updated systematic review and meta-analysis.. Allergy. 2023. PMID 37405695. DOI 10.1111/all.15801. (abstract)
- Viguiliouk E, Glenn AJ, Nishi SK, et al.. Associations between Dietary Pulses Alone or with Other Legumes and Cardiometabolic Disease Outcomes: An Umbrella Review and Updated Systematic Review and Meta-analysis of Prospective Cohort Studies.. Adv Nutr. 2019. PMID 31728500. DOI 10.1093/advances/nmz113. (abstract)
- Wei Y, Lv J, Guo Y, et al.. Soy intake and breast cancer risk: a prospective study of 300,000 Chinese women and a dose-response meta-analysis.. Eur J Epidemiol. 2020. PMID 31754945. DOI 10.1007/s10654-019-00585-4. (abstract)
- Wu Q, Wang M, Sciarappa WJ, et al.. LC/UV/ESI-MS analysis of isoflavones in Edamame and Tofu soybeans.. J Agric Food Chem. 2004. PMID 15137811. DOI 10.1021/jf035053p. (abstract)
- . U.S. FDA: Food Allergies. . . (full-text)
- . GBIF Backbone: Glycine max (L.) Merr. (usageKey 5359660). . . (full-text)
- . MedlinePlus: Food allergy. . . (full-text)
- . MedlinePlus: Potassium in diet. . . (full-text)
- . MedlinePlus: Vitamin K in diet. . . (full-text)
- . NCCIH: Soy: Usefulness and Safety. . . (full-text)
- . NHS: 5 A Day, what counts?. . . (full-text)
- . NIDDK: Eating, Diet, and Nutrition for Gas in the Digestive Tract. . . (full-text)
- . USDA FoodData Central: Edamame, frozen, unprepared (FDC 168410). . . (full-text)
- . USDA FoodData Central: Soybeans, green, cooked, boiled, drained, without salt (FDC 169283). . . (full-text)
- . USDA FoodData Central: Soybeans, mature seeds, raw (FDC 174270). . . (full-text)
Where to buy
Check the label first. Whatever you buy, look for these:
- A recent packed-on date: very old dried beans cook unevenly
- Organic or not, and the country of origin
- Whether you want dried or canned
- Soak and cook thoroughly; some raw beans are unsafe
Talk to a pharmacist or doctor before you start any supplement, especially if you take medicines. See the Safety tab for interactions.
Support our free guides: as an Amazon Associate we earn from qualifying purchases. Full disclosure.